Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach – a population-based study

Fig. 2

Gene fusions and mutations identified by the RNA-Seq and FISH methods. The cohort is divided into patients with ABL-class fusions, JAK-STAT pathway fusions, other JAK-STAT–activating mutations, Ras pathway mutations, and cases with other or no gene variants

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us